Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
KROS
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
KROS: Keros Therapeutics, Inc. Stock Analysis | finqOS
KROS
$11.08
−2.72%
Lists
Call KROS
Keros Therapeutics
KROS
Back
Lists
Call KROS
$11.08
−$0.31 · −2.72%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Up
0.45%
in three months and
15%
of the way up its 52-week range.
Call KROS
Loading chart data...
Signal state